Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects

Olivier Barret; David Alagille; Sandra Sanabria; Robert A. Comley; Robby M. Weimer; Edilio Borroni; Mark Mintun; Nicholas Seneca; Caroline Papin; Thomas Morley; Ken Marek; John P. Seibyl; Gilles D. Tamagnan; Danna Jennings

doi:10.2967/jnumed.116.182881

Research ArticleNeurology

Kinetic Modeling of the Tau PET Tracer ¹⁸F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects

Olivier Barret, David Alagille, Sandra Sanabria, Robert A. Comley, Robby M. Weimer, Edilio Borroni, Mark Mintun, Nicholas Seneca, Caroline Papin, Thomas Morley, Ken Marek, John P. Seibyl, Gilles D. Tamagnan and Danna Jennings

Journal of Nuclear Medicine July 2017, 58 (7) 1124-1131; DOI: https://doi.org/10.2967/jnumed.116.182881

Olivier Barret

1Molecular NeuroImaging LLC, New Haven, Connecticut

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David Alagille

1Molecular NeuroImaging LLC, New Haven, Connecticut

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sandra Sanabria

2Genentech Research and Early Development, Genentech, South San Francisco, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert A. Comley

3Pharma Research and Early Development, F. Hoffmann-La Roche, Konzern-Hauptsitz, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robby M. Weimer

2Genentech Research and Early Development, Genentech, South San Francisco, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Edilio Borroni

3Pharma Research and Early Development, F. Hoffmann-La Roche, Konzern-Hauptsitz, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark Mintun

4Avid Radiopharmaceuticals, Philadelphia, Pennsylvania; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nicholas Seneca

5Product Development, F. Hoffmann-La Roche, Konzern-Hauptsitz, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Caroline Papin

1Molecular NeuroImaging LLC, New Haven, Connecticut

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thomas Morley

1Molecular NeuroImaging LLC, New Haven, Connecticut

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ken Marek

1Molecular NeuroImaging LLC, New Haven, Connecticut

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John P. Seibyl

1Molecular NeuroImaging LLC, New Haven, Connecticut

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gilles D. Tamagnan

1Molecular NeuroImaging LLC, New Haven, Connecticut

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Danna Jennings

1Molecular NeuroImaging LLC, New Haven, Connecticut

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 58, Issue 7

July 1, 2017

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Kinetic Modeling of the Tau PET Tracer ¹⁸F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects

Journal of Nuclear Medicine Jul 2017, 58 (7) 1124-1131; DOI: 10.2967/jnumed.116.182881

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Kinetic Modeling of the Tau PET Tracer ¹⁸F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects

Journal of Nuclear Medicine Jul 2017, 58 (7) 1124-1131; DOI: 10.2967/jnumed.116.182881

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

CenTauR: Towards a Universal Scale and Masks for Standardizing Tau Imaging Studies
The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification
{alpha}-Synuclein PET and Parkinson Disease Therapeutic Trials: Ever the Twain Shall Meet?
An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with 18F-PM-PBB3 (18F-APN-1607)
Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of 18F-PI-2620 PET for the Assessment of Tau Deposits in the Human Brain
Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span
Evaluation of 18F-RO-948 PET for Quantitative Assessment of Tau Accumulation in the Human Brain

Google Scholar

Neurology

Dopamine D₁ Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Tau^IQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans

Show more Neurology

Clinical

Tau^IQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
Addition of ¹³¹I-MIBG to PRRT (⁹⁰Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors

Show more Clinical

Keywords

Tau protein
Alzheimer
PET
18F-AV-1451
kinetic modeling

Main menu

User menu

Search

Kinetic Modeling of the Tau PET Tracer ¹⁸F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Neurology

Clinical

Similar Articles

Keywords